CD38 and Miyoshi myopathy: Much due to its decade-long history as a gold-standard surface marker to detect MM cells in the bone-marrow and in peripheral blood, Syndecan-1/CD138 is an undiscussed prognostic factor in such tumour entity, when considered alone or in combination with CD38.